Nicole Bjorklund

Nicole Bjorklund, PhD, is the Director of Research & Grants at The Association for Frontotemporal Degeneration (AFTD) since August 2024. Previously, Nicole served as the Director of Translational Research & Development at Cohen Veterans Bioscience from July 2021 to May 2024 and as the Assistant Director of Scientific Affairs at the Alzheimer's Drug Discovery Foundation from July 2018 to July 2021, focusing on biomarker programs through the Diagnostics Accelerator Initiative. At Albert Einstein College of Medicine, Nicole held dual roles as Research Assistant Professor and Translational Core Administrator, overseeing operational management of the Biomarker Analytic Research Core and Einstein Biorepository. Nicole’s early career included positions as a Scientific Associate at Precept Medical Communications and postdoctoral fellowships at the University of Texas Medical Branch and the University of Texas MD Anderson Cancer Center, emphasizing neurodegenerative diseases and protein extraction methodologies. Academic credentials include a PhD in Biochemistry and Biophysics from Washington State University and a BS in Chemistry and Biochemistry from Boise State University.

Location

New York, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


The Association for Frontotemporal Degeneration (AFTD)

AFTD establish an institution dedicated to advancing FTD research, providing information, education, and support, as well as raising awareness of this uncommon and especially devastating disease, the AFTD, in whom mission is to improve the quality of life for those affected by FTD and drive research toward a cure, collaborated with a collective ofdedicated FTD care partners and medical professionals. With a committed board of directors, a robust volunteer network, and medical and scientific advisers from the leading experts from across the world, the company has developed into a major international structure on FTD and young onset dementia. AFTD has profited from kind foundation and donor funding, including gifts from the fund.


Industries

Employees

11-50

Links